STAAR Surgical Generates Cash From Operations During Seco...(------------ US ...),Health

Date:8/3/2009

------------ US 8,391 - 8,391 9,722 International 29,009 (1,325) 30,334 28,903 ---------------------------------------- Total 37,400 (1,325) 38,725 38,625 ======================================== Q2 2009 vs. Q2 2008 -------------------- Sales in Constant Currency As Reported Ex-Currency -------------------------------------- $Change %Change $Change %Change -------------------------------------- US (1,045) -20% (1,045) -20% International (503) -3% 224 1% Total (1,548) -7% (821) -4% Sales in Constant Currency As Reported Ex-Currency -------------------------------------- $Change %Change $Change %Change -------------------------------------- US (1,331) -14% (1,331) -14% International 106 0% 1,431 5% Total (1,225) -3% 100 0% Six Months As Reported Six Months Statement of % of July 3, % of June 27, Purchase Ex Purchase % of Operations Sales 2009 Sales 2008 A/C Chgs A/C Chgs Sales --------------------------------------------------------- Net sales 100% $37,400 100% $38,625 $- $38,625 100% Cost of sales 44% 16,397 50% 19,336 (1,500)
'/>"/>

SOURCE STAAR Surgical Company Copyright©2009 PR Newswire. All rights reserved

1 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
Related medicine news :

1. STAAR Surgical to Present at BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York
2. Review of STAARs Application for the Visian(R) Toric Implantable Collamer(R) Lens by FDA to Resume
3. Review of STAARs Application for the Visian(R) Toric Implantable Collamer(R) Lens by FDA to Resume
4. STAAR Surgical Announces Second Quarter 2009 Earnings Release Date And Conference Call
5. Richard A. Meier Appointed to STAAR Surgical Board of Directors
6. STAAR Surgical Completes Common Stock Offering
7. STAAR Surgical Receives Japanese Clearance for the KS-Ni Preloaded IOL Injector System
8. STAAR Surgical Announces First Quarter 2009 Earnings Release Date and Conference Call
9. STAAR Surgical Reports 14% Fourth Quarter Revenue Growth
10. STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer(R) Material for Accommodating Intraocular Lenses
11. STAAR Surgical Reports 33% Third Quarter Revenue Growth